Fig. 1From: Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims dataOne-year prevalence of autoimmune comorbidities in individuals with metastatic melanoma, non-metastatic melanoma, and in the general population, from 2004 to 2014Back to article page